Live feed
Filing
SC 13G/A
SC 13G/A0000935836-24-000715·Crinetics Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
CRINETICS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 22663K107
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,288,120
- Percent of class
- 4.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000715
- Form type
- SC 13G/A
- Filer
- Crinetics Pharmaceuticals, Inc.
- CIK
- CIK 1658247
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership